Skip to main content
Decorative image of the AMR Learning Lounge

LL Editorial: Sepsis Care Diminished by Antimicrobial Resistance

SUMMARY

Learning Lounge Editorial | October 2024

The escalating threat of antimicrobial resistance (AMR) hampers effective sepsis treatment. As traditional broad-spectrum antibiotics face diminishing efficacy, Sébastien Spinali, MD, explains the urgent need for innovative diagnostic tools and refined treatment protocols to balance timely sepsis intervention with antimicrobial stewardship (AMS) practices. He encourages healthcare professionals to integrate fast and accurate clinical diagnostics and evidence-based strategies to enhance patient outcomes while combating the growing challenge of AMR in sepsis management.

FEATURED EXPERTS

Sébastien Spinali, MD, Vice President Global Marketing - Microbiology Solutions, bioMérieux


GET STARTED

Explore strategies for managing sepsis and AMR concurrently.

Read now

Filename
LL Editorial_Sepsis Care Diminished by AMR - Sebastien Spinali_October 2024.pdf
Size
448 KB
Format
application/pdf

Subscribe to Receive Our Quarterly Learning Lounge Highlights Email

We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.


U.S. bioMérieux Solutions

Global Solutions

Learn More

Discover bioMérieux's comprehensive sepsis solutions supporting optimized antibiotic therapy for better patient care.

U.S. bioMérieux Solutions

US Solutions

Sepsis

Learn how bioMérieux supports the continuum of sepsis care with diagnostic solutions that span the entire treatment workflow.

PUBLISHED BY

October 2024


SHARE THIS ARTICLE: